Annexon Inc (ANNX) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $5.38
• Market Cap: $758.69M
• EPS: $-1.41
• 52-Week High: $7.18
• 52-Week Low: $1.28

Market Sentiment

Annexon Inc currently has a Neutral sentiment score of 0.11.

About Annexon Inc

Annexon, Inc. is a clinical-stage biopharmaceutical company based in South San Francisco, California, focusing on revolutionary therapies for autoimmune and neurodegenerative diseases. Harnessing its proprietary technology platforms, the company is developing innovative treatments that aim to restore immune balance and enhance neuronal health. With a promising pipeline of drug candidates targeting significant unmet medical needs, Annexon is strategically positioned as a leading innovator with...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Annexon Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does ANNX pay dividends?

Annexon Inc (ANNX) does not currently pay a regular dividend.

What is ANNX's market cap?

Annexon Inc (ANNX) has a market capitalization of $758.69M with a current stock price of $5.38.